Peter Madrid, Head of Scientific Discovery at Synfini, Joins Other Expert Speakers to Lead a National Academies of Sciences Workshop on AI for Scientific Discovery
October 11, 2023 14:29 ET
|
Synfini
MENLO PARK, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Synfini, Inc., a pioneer in agile chemistry whose advanced, automated molecular discovery platform is transforming drug discovery, today...
Global CADD Market Expected to Reach $7.81 Billion by 2030, Driven by Growing Demand for Advanced Drug Discovery
September 29, 2023 05:03 ET
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Computer-aided Drug Discovery Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ...
Technology-enabled Drug Discovery Research Report 2023: AI Integration into Drug Discovery Remains on an Upward Trajectory, Increasing Almost 40% as of 2022
August 08, 2023 04:43 ET
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Growth Indicators for Technology-enabled Drug Discovery" report has been added to ResearchAndMarkets.com's offering. Innovative Business Models...
Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston
May 12, 2023 16:39 ET
|
InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the...
Outlook on the Deep Learning Drug Discovery and Diagnostics Global Market to 2035: by Therapeutic Areas and Key Geographical Regions
March 16, 2023 05:53 ET
|
Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Deep Learning Market in Drug Discovery and Diagnostics: Distribution by Therapeutic Areas and Key Geographical Regions: Industry Trends and Global...
Global In-Silico Drug Discovery Market Report 2022: Industry Outlook and Demand Forecast to 2030 Featuring In-silico Medicine, Evotec, Charles River Labs, WuXi AppTec, Ligand Pharma, Simulation Plus
March 01, 2023 10:28 ET
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Global In-Silico Drug Discovery Market Report: By Product, Workflow, Technology, End-user - Industry Outlook and Demand Forecast to 2030" report has...
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
February 08, 2023 09:00 ET
|
InSilico Medicine
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that...
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
January 10, 2023 09:00 ET
|
InSilico Medicine
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of...
Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Savings of $8.57 Billion Enabled by AI
January 04, 2023 06:48 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering. ...
Computer-Aided Drug Discovery Global Market Report 2022: Demand for Novel Drugs to Treat CVD Conditions Fuels Growth
November 07, 2022 08:38 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report...